Successful use of trametinib and dasatinib combined with chemotherapy in the treatment of Ph-positive B-cell acute lymphoblastic leukemia: A case report

RATIONALE: Relapsed or refractory acute lymphoblastic leukemia poses a significant clinical challenge due to its poor prognosis, showing survival rates of less than a year even with the use of novel therapies. In this report, we describe the safe and effective use of trametinib combined with dasatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Shen, Shu-Hong, Hu, Bin-Fei, Wang, Guan-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238268/
https://www.ncbi.nlm.nih.gov/pubmed/34160436
http://dx.doi.org/10.1097/MD.0000000000026440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238268/
https://www.ncbi.nlm.nih.gov/pubmed/34160436
http://dx.doi.org/10.1097/MD.0000000000026440

Ejemplares similares